Figure 8.
Computational prediction and molecular docking of drugs targeting CD180 and COA3A. (A) Predicted drugs targeting CD180 and COA3.Five drugs (benzo(a)pyrene, cadmium, cadmium chloride, di-n-butylphosphoric acid, and sodium arsenite) were found to co-target both biomarkers (highlighted in red). (B) Molecular docking analysis of CD180 and benzo(a)pyrene. (C) Docking results for CD180 and di-n-butylphosphoric acid.
